Hypodermic Needles Articles & Analysis: Older
2 news found
Micron’s applicator-free technology is well-suited for the administration of vaccines and, in particular, for measles-rubella vaccination in low- and middle-income countries as it is designed to offer the following benefits and advantages over vaccination by standard hypodermic needle and syringe: strong immune response due to vaccine delivery to the skin, ...
This comprises of a 1 billion syringes per annum syringe plant, 1 billion per annum hypodermic needles plant a 105 million sets per annum intravenous (IV)-Giving-Set Plant, a 90 million litres per annum IV solutions/medication and injectables plant, and a 14 megawatt electrical output captive gas-fired power ...